ARTICLE | Clinical News
Zanolimumab: Development discontinued
October 13, 2008 7:00 AM UTC
Genmab said it will discontinue development of zanolimumab, though patients already enrolled in an ongoing Phase III trial for CTCL and a Phase II trial for non-cutaneous T cell lymphoma (NCTCL) would...